BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2440223)

  • 1. Immunohistochemical demonstration of serum proteins in human cerebral gliomas.
    Seitz RJ; Wechsler W
    Acta Neuropathol; 1987; 73(2):145-52. PubMed ID: 2440223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical investigation of serum proteins in human brain gliomas].
    Li NY
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):45-7. PubMed ID: 1327689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular serum proteins in cerebral gliomas and metastatic tumours: an immunoperoxidase study.
    Brett M; Weller RO
    Neuropathol Appl Neurobiol; 1978; 4(4):263-72. PubMed ID: 360095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical demonstration of immunoglobulins and albumin in human brain tumors.
    Wolff M; Böker DK
    Clin Neuropathol; 1989; 8(2):72-8. PubMed ID: 2541957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histological classification of human gliomas: state of art and controversies].
    Figarella-Branger D; Bouvier C
    Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of chondroitin sulfate in human gliomas.
    Bertolotto A; Goia L; Schiffer D
    Acta Neuropathol; 1986; 72(2):189-96. PubMed ID: 3103373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.
    Higuchi M; Ohnishi T; Arita N; Hiraga S; Hayakawa T
    Acta Neuropathol; 1993; 85(5):481-7. PubMed ID: 7684178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas.
    Mitsuka K; Kawataki T; Satoh E; Asahara T; Horikoshi T; Kinouchi H
    Neurosurgery; 2013 Jun; 72(6):1031-8; discussion 1038-9. PubMed ID: 23426156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of gliomas.
    Kattar MM; Kupsky WJ; Shimoyama RK; Vo TD; Olson MW; Bargar GR; Sarkar FH
    Hum Pathol; 1997 Oct; 28(10):1166-79. PubMed ID: 9343324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin expression patterns and cells of monocyte lineage: relationship in human gliomas.
    Kulla A; Liigant A; Piirsoo A; Rippin G; Asser T
    Mod Pathol; 2000 Jan; 13(1):56-67. PubMed ID: 10658911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression and distribution of heparan sulfate proteoglycans in human gliomas.
    Steck PA; Moser RP; Bruner JM; Liang L; Freidman AN; Hwang TL; Yung WK
    Cancer Res; 1989 Apr; 49(8):2096-103. PubMed ID: 2522816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas.
    de la Fuente C; Pumarola M; Blasco E; Fernández F; Viu J; Añor S
    Vet J; 2014 Jun; 200(3):387-92. PubMed ID: 24745770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
    Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The metabolism of 28 serum proteins in a human liver transplantation (author's transl)].
    Müller HE; Lie TS
    Z Immunitatsforsch Exp Klin Immunol; 1973 May; 145(3):250-74. PubMed ID: 4143235
    [No Abstract]   [Full Text] [Related]  

  • 17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular kinetics of cerebral glioma: study of the proliferative activity using monoclonal antibody Ki 67. Apropos of 60 cases].
    Parent M; Blond S; Gosset P; Lejeune JP; Lesoin F; Dhellemmes P; Jomin M; Christiaens JL; Dupont A
    Arch Anat Cytol Pathol; 1990; 38(3):81-5. PubMed ID: 2363592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of pigment epithelium derived factor expression in glioma progression.
    Guan M; Yam HF; Su B; Chan KP; Pang CP; Liu WW; Zhang WZ; Lu Y
    J Clin Pathol; 2003 Apr; 56(4):277-82. PubMed ID: 12663639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin histochemistry of human gliomas.
    Wang XC; Kochi N; Tani E; Kaba K; Matsumoto T; Shindo H
    Acta Neuropathol; 1989; 79(2):176-82. PubMed ID: 2596266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.